Veteran life sciences CRO executive and Blue Sky Biotech founder joins flow cytometry CRO to lead commercial strategy ...
Rad’s StarBright™ Dyes for Flow Cytometry and Western Blot Applications in Immunology Research. HERCULES, Calif.—May 05, 2025 ...
Imagine being tasked with counting every blade of grass in a field, noting every single species as you go. This is not far ...
CAR-modified stem cell memory T cells show greater expansion and persistence than standard CAR T cells, enabling complete ...
Enein, MD, PhD, for a measurement-driven approach that advances cell therapy translation, from high-dimensional analytics to ...
Affinity Technologies, Inc. , a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today announced a pilot study with Brooke Army Medical Center (BAMC) to ...
When this is done well, biomarkers accelerate decision-making, reduce uncertainty, and ultimately bring improved therapies to patients faster. When this is done poorly, however, biomarkers can add ...
At the 2026 BiOS conference in San Francisco, researchers presented a biosensing platform aimed at improving how living cells and tissues are monitored during drug bioprocessing. Known as TissueSense, ...
Ardena opens bioanalytical lab in Somerset to support client studies, strengthen precision medicine development: Somerset, New Jersey Ard ...
CRO: Contract Research Organization, a company providing outsourced research services to the pharmaceutical, biotechnology, and medical device industries. Cytek Cloud: The company’s bioinformatics ...
Modulight estimates that the Company’s revenue and profitability will increase compared to the previous year. Modulight Corporation announced on April 21st, 2026 that it will begin providing financial ...
Modulight Corporation | Company Release | April 24, 2026 at 10:30:00 EEST This release is a summary of Modulight's interim report for January-March 2026. The whole report is attached to this stock exc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results